Navigation Links
Penn Medicine's new center for personalized diagnostics unlocks cancer's secrets
Date:4/5/2013

r a wider range of cancer patients. Results are available within two weeks twice as fast as most commercially available testing panels. All new and relapsed Abramson Cancer Center patients will receive this testing conducted via simple blood tests and/or biopsy of tumor tissue or bone marrow as part of their evaluation and diagnostic process. Interpretation of results is communicated one-on-one to patients and their caregivers by physicians and genetic counselors.

In contrast to the CPD's offerings, individual genetic tests which now proliferate in the marketplace, even for healthy people who may be interested in going on a spelunking expedition through their DNA are time consuming and expensive to conduct, and they often yield information which is not clinically actionable. When these tests are offered for cancer patients, patients are often left with only a veritable alphabet soup detailing genetic information, with few plans for how to use those findings to conquer their cancer.

Since the CPD began operating in early 2013, however, tests in 80 percent of patients revealed genetic mutations that may be used to alter their treatment course or clarify their prognosis. The results are playing a role in:

  • Matching patients with existing therapies designed to target mutations previously associated only with different cancers. For instance, some lung cancer patients exhibit mutations of the BRAF gene, which is targeted by drug Vemurafenib, initially developed and approved for melanoma. Testing in the Center for Personalized Diagnostics is helping clinicians make new connections that will expand the indications for existing drugs.

  • Helping physicians determine which treatments a patient will respond to, or how well they will tolerate a particular treatment. Patients with the blood cancer acute myelogenous leukemia who express a mutation known as DNMT3A, for instance, are known to respond to higher doses of the drug
    '/>"/>

Contact: Holly Auer
holly.auer@uphs.upenn.edu
215-200-2313
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Research and Markets Announces the Addition of a New Report, "Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide" to Their Offering
2. Millions of people in Asia potentially exposed to health risks of popular herbal medicines
3. Handheld device for detecting counterfeit and substandard medicines tested by PQM
4. Medicines quality workshop to address standards for microbiological contamination, bioburden control
5. Growing medicines in plants requires new regulations
6. Zane Benefits Publishes Information About Over-the-Counter (OTC) Medicines, Drugs and HRAs
7. Popular pain-relieving medicines linked to hearing loss in women
8. Strategy developed to improve delivery of medicines to the brain
9. Toward medicines that recruit the bodys natural disease-fighting proteins
10. New research reveals extent of poor-quality antimalarial medicines in South American countries
11. New technology represents next-generation tool for detecting substandard and counterfeit medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... York, New York (PRWEB) September 21, 2014 ... ) continue to move forward in Pennsylvania’s Philadelphia ... According to court documents, the proceeding’s next monthly ... (Risperdal Litigation, case number 100300296) , “Our Firm ... filed Risperdal lawsuits in this litigation. We are ...
(Date:9/21/2014)... Best Cheap Hosting USA, one of the ... and GreenGeeks are the best Reseller hosting suppliers in ... hosting supplier. Actually, these companies have outperformed their competitors ... People can get the best web hosting at affordable ... to the manager, reseller hosting is a very popular ...
(Date:9/21/2014)... TX (PRWEB) September 21, 2014 ... Chinese Fenofibrate (CAS 49562-28-9) Industry, 2009-2019 is ... Global and Chinese Fenofibrate (CAS 49562-28-9) industry. ... of Fenofibrate (CAS 49562-28-9) including its classification, ... global and China’s top manufacturers of Fenofibrate ...
(Date:9/21/2014)... September 21, 2014 More than ... been added over the past month to a ... serious cardiovascular injuries caused by the dialysis concentrate, ... updated on September 15th shows 2,089 cases filed ... District Court, District of Massachusetts. These claims were ...
(Date:9/21/2014)... BambooIndustry.com, an experienced producer of natural bamboo items, has ... http://www.bambooindustry.com/products/bamboo-panel/ ). The company’s excellent panels are very popular ... discounted prices now, from 10 to 30 percent off. ... are available in many specifications; they are promised to ... finely manufactured by qualified workers. They are specially offered ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 4Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2
... Inc.,(NYSE: ZMH ; SWX: ZMH), a leader in the ... upcoming investor,conferences: -- November 27, 2007 -- 19th Annual ... York, New York, 9:00 a.m. Eastern Time -- December ... York, New York, 9:30 a.m. Eastern ...
... -- China Medical,Technologies Inc. (the "Company") (Nasdaq: ... company that develops, manufactures and markets advanced ... focused ultrasound tumor,therapy systems, today announces the ... and Dr. Yuedong Li as member for ...
... SALEM, Mass., Nov. 19 LaVoie Group, a ... today announced,that it has been selected as agency ... The GI Company, of Framingham, MA. Donna ... engaged in,providing strategic communications counsel and tactical execution ...
... Support for True Wealth Measures: Three-Quarters Say Governments, ... Environmental Progress, BRUSSELS, Belgium, Nov. 19 ... should look beyond,economics, and include health, social and ... believe that economic growth,alone is the most important ...
... November 19 ThalesNano Inc.,and the Christian ... Karl-Franzens-University in Graz today announced a scientific,collaboration ... focus,on the application of flow reactors for ... utilizing ThalesNano,s background in,continuous processing. ThalesNano and ...
... a dollar value has been attached to the high cost ... that reveals a massive annual cost of $34.3 billion -- ... grappling with pain. The price tag of pain includes ... MBF Foundation study The High Price of Pain: The Economic ...
Cached Medicine News:Health News:China Medical Technologies Announces Changes in Board of Directors and Appointment of Chief Technology Officer 2Health News:China Medical Technologies Announces Changes in Board of Directors and Appointment of Chief Technology Officer 3Health News:LaVoie Group Adds Two New Companies to Its Life Science Client Roster 2Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 2Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 3Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 2Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 3Health News:First study of Australia's high cost of pain reveals $34 billion price tag 2
(Date:9/19/2014)... -- Five MinuteClinic walk-in medical clinics are opening inside select CVS/pharmacy ... clinics opened in Memphis and ... added in Springfield on September 24 and ... to open October 22.  MinuteClinic is the largest and fastest growing ... . The Memphis -area clinics ...
(Date:9/19/2014)... 19, 2014 According to ... (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, Pharmaceutical, ... & Rotary) & Geography - Global Trends & ... segments the lyophilization market on the basis of ... projections of the market size of each of ...
(Date:9/19/2014)... , Sept. 19, 2014  Pressure BioSciences, ... announced it has received and approved all parts ... instruments and has begun to manufacture the new ... instrument will be ready for shipment by mid-October ... and released at a rate of about one ...
Breaking Medicine Technology:MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today ... will present a company update at the Morgan Stanley Global ... at 10:55 a.m. ET.   Interested parties may ... the investor section of the BioMarin website, www.BMRN.com . ...
... Sept. 7, 2011 Generex Biotechnology Corporation ( ... Fletcher, the Company,s President & Chief Executive Officer, ... Company,s wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ... Rodman & Renshaw 13th Annual Healthcare Conference.  The ...
Cached Medicine Technology:BioMarin to Present at the Morgan Stanley Global Healthcare Conference 2Generex to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 2Generex to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 3
... & Transfer System is a patent-pending disposable, ... procedures simpler for the physician and their ... an office-based technique. LipiVage™ improves upon traditional ... a need to centrifuge, decant or expose ...
... Type B) Injectable Solution, the only Botulinum ... demonstrated in numerous published studies to be ... Delivered as a purified, ready-to-use solution, ... a simpler way to significantly reduce abnormal ...
... is a simple, nonsurgical, physician-administered treatment that ... lines between the brows in people from ... is the only treatment of its type ... (FDA). BOTOX® Cosmetic is a purified ...
Inquire...
Medicine Products: